We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Diagnostics

Image: Researchers have identified an easily detectable genetic variant that can predict early right heart failure in PAH patients (photo credit: 123RF)

Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension

Researchers identify a genetic marker that predicts early right-heart failure in PAH, enabling simple swab-based risk stratification. More...
08 Apr 2026
Image: MammaPrint is a 70‑gene expression test that stratifies risk of distant metastasis into UltraLow, Low, High 1, and High 2 categories (photo courtesy of Agendia)

Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers

Two genomic subtyping assays identify aggressive HR+/HER2– tumors driving racial survival disparities. More...
08 Apr 2026
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

Simple Blood Test Enables Multi-Disease Detection from Single Sample

A new cfDNA methylation assay screens for multiple cancers and organ diseases from one blood draw with tissue-of-origin mapping. More...
07 Apr 2026
Image: FINDER is the first molecular point-of-care platform with both FDA 510(k) clearance and CLIA waiver that combines molecular testing with chemistry, coagulation, and immunoassay capabilities on a single multifunctional system (photo courtesy of Baebies)

Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

Baebies has received FDA 510(k) clearance and CLIA waiver for the FINDER Flu A&B/SARS-CoV-2 Test. More...
07 Apr 2026
Image: Monitoring ctDNA is a powerful tool to assess the absence or presence of MRD (Photo courtesy of Natera)

ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery

A circulating tumor DNA-based molecular residual disease test identifies older ER+/HER2- breast cancer patients who may forgo surgery. More...
06 Apr 2026
Image: Caris Detect uses AI models to analyze peripheral blood for subtle signals of early-stage cancer (photo credit: Adobe Stock)

WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity

A new WGS-based multi-cancer blood test shows stage-stratified sensitivity with high specificity. More...
06 Apr 2026
image: HPV DNA (ctDNA) measured in blood could help tailor treatment for HPV-related throat cancer (photo credit: Adobe Stock)

Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer

New data show circulating tumor HPV DNA, read with pathology, improves risk stratification to tailor therapy in throat cancer. More...
03 Apr 2026
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Automated Urinalysis Solution
UN-9000


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.